In November 2020, the Centre of Research Excellence in Medicines Intelligence (MI-CRE) received a $2.5 million five-year grant from the NHMRC for the purpose of delivering 'real-world' evidence on the use and outcomes of medicines in Australia.
The MI-CRE is led by Professor Sallie Pearson from UNSW Medicine and Health’s School of Population Health and is a truly national collaboration that includes nine other Chief Investigators and ten Associate Investigators from universities across Australia. The MI-CRE provides an opportunity for researchers in institutions across the country to collaborate more closely on key research priorities and accelerate the generation and translation of evidence about real-world medicine use and outcomes.
The MI-CRE was established in recognition of the major health and economic impact from medicine overuse and misuse, and in response to the 2019 announcement by the Federal Minister for Health, The Hon. Greg Hunt, that quality use of medicine and medicine safety is a National Health Priority. We are developing a coordinated research program that will accelerate the development and translation of evidence about real-world medicine use and outcomes, leading to major improvements in the quality use of medicines and reductions in medicine-related harm. The MI-CRE develops and delivers new knowledge of medicines in Australia for use by regulators and payers, that can be translated directly into policy and practice, improving responsiveness to current and emerging policy imperatives.
We use population-based linked data (including through the use of 'big data platforms') and sophisticated methods to study the association between the effects of medicines, how they are used in practice, and the resultant benefits, harms and costs. We engage with policymakers to develop and scale-up sustainable approaches for timely evidence generation and research translation; and we develop innovative training and on-the-job experience to grow the next generation of research leaders.
To support our program of work, we have developed the following Portfolios of expertise that will integrate at both the program and project levels to support our goals:
The Medicines Intelligence CRE brings together Australia’s leading researchers in pharmacoepidemiology and related fields, and key stakeholders to:
The MI-CRE Project Incubator initiative provides an opportunity for early- and mid-career medicines intelligence researchers to engage with relevant stakeholders from government, industry, the research community, and consumers to gain valuable feedback and input on their research proposals and develop new collaborations in a supportive environment.
The 1st Annual Research Symposium and Policy Forum was held as a virtual event on the 16th September 2021. It featured Prof Robert Platt from from the Canadian Network of Observational Drug Effect Studies (CNODES).
The 2022 theme focused on knowledge translation by bridging the gap between real-world evidence and smarter medical use. View key recordings and abstract sessions.
This year's theme focuses on mobilising data to accelerate real-world evidence generation.